Important Information and Limitations:

tellmeGen Reports on Genetic Vulnerability to Health Conditions and Hereditary Conditions: The tellmeGen ULTRA genetic analysis performs whole-genome sequencing (WGS) at 30x to detect common, rare, and some novel variants in saliva DNA, reporting on ancestry, traits, wellness, multifactorial predisposition, carrier status, and pharmacogenetics. The information is educational, not diagnostic or for treating diseases. Ancestry affects resolution (probabilistic, dependent on reference databases) and traits (published associations, not complete). It describes risk or carrier variants, but does not eliminate residual risks (undetected variants possible). It does not report current health, medical decisions, fetal, or neonatal risk. For genes like BRCA1/BRCA2, it analyzes the whole gene; VUS possible and absence does not exclude risks. Confirm clinically. tellmeGen Pharmacogenetic Reports: Detects variants that influence drug metabolism or response, for medical discussions. It does not determine efficacy/safety alone; factors like age, comorbidities, or dosage are key. Complex haplotypes may require extra tests. Confirm with independent tests before actions. Warning: Do not use to change treatments without prior consultation with a medical professional; it may not analyze all variants (possible limitations: CNV, expansions, mosaicisms; evidence evolves). It does not replace professionals or genetic counseling (possible emotional impact). Consult a doctor to avoid side effects. Reports may vary due to updates.